Clinical Trials · NCT04788511
Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 529
- Start date
- Mar 2021
- Locations
- 146 sites, 13 countries
- Primary endpoint
- Change in Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS)